8-K: Glucotrack Changes Auditors Amidst Going Concern Doubts and Internal Control Weaknesses

Glucotrack, Inc. has appointed CBIZ CPAs P.C. as its new independent registered public accounting firm, replacing Grant Thornton, which had previously raised substantial doubt about the company's ability to continue as a going concern and noted material weaknesses in internal controls.

Summary

• Glucotrack, Inc. dismissed Fahn Kanne & Co. Grant Thornton Israel (Grant Thornton) as its independent registered public accounting firm, effective July 18, 2025.
• The Audit Committee approved the engagement of CBIZ CPAs P.C. (CBIZ) as the new independent registered public accounting firm for the fiscal year ended December 31, 2025, effective July 18, 2025.
• Grant Thornton's reports for the past two fiscal years (ended December 31, 2024 and 2023) did not contain adverse opinions or disclaimers, nor were they qualified or modified, except for an explanatory paragraph regarding substantial doubt about the Company's ability to continue as a going concern.
• No disagreements on accounting principles, practices, financial statement disclosure, or auditing scope/procedure were reported with Grant Thornton during the fiscal years ended December 31, 2024 and 2023, and the subsequent interim period through July 18, 2025.
• Management identified material weaknesses in internal control over financial reporting related to general IT controls, lack of sufficient accounting personnel, and inadequate segregation of duties, as disclosed in the Form 10-K for the year ended December 31, 2024.
• The Audit Committee discussed these material weaknesses with Grant Thornton, and the Company authorized Grant Thornton to respond fully to inquiries from CBIZ regarding these matters.
• The Company did not consult CBIZ on accounting principles or audit opinions prior to their engagement.
• Glucotrack will file an amendment to the Form 8-K within two business days of receiving a letter from Grant Thornton to the SEC, stating whether Grant Thornton agrees with the Company's disclosures in this report.

Sentiment

Score: 2

Explanation: The sentiment is negative due to the explicit mention of 'substantial doubt about the Company's ability to continue as a going concern' and 'material weaknesses in internal control over financial reporting.' While the change in auditor itself is administrative, the underlying reasons and disclosures are significant red flags regarding the company's financial health and operational integrity.

Positives

• No disagreements were reported with the dismissed auditor, Grant Thornton, on accounting principles or auditing procedures.
• The company has promptly engaged a new independent registered public accounting firm, CBIZ, ensuring continuity in audit services.

Negatives

• Grant Thornton's audit reports included an explanatory paragraph indicating substantial doubt about the Company's ability to continue as a going concern.
• Management identified material weaknesses in internal control over financial reporting, specifically related to general IT controls, insufficient accounting personnel, and inadequate segregation of duties.

Risks

• Substantial doubt about the Company's ability to continue as a going concern, as noted by the former auditor.
• Material weaknesses in internal control over financial reporting, including issues with general IT controls, insufficient accounting personnel, and inadequate segregation of duties, which could lead to financial misstatements or fraud.

Future Outlook

The filing does not provide specific forward-looking statements or financial guidance, focusing solely on the administrative change of the independent registered public accounting firm.

Management Comments

• Paul Goode, Chief Executive Officer, signed the report on behalf of Glucotrack, Inc.

Industry Context

This administrative change in auditing firms is specific to Glucotrack, Inc. and does not directly reflect broader industry trends. However, the underlying issues of 'going concern' and 'material weaknesses in internal controls' are critical indicators of a company's financial health and operational integrity, which are closely scrutinized across all industries, particularly in the medical device or healthcare technology sector where regulatory compliance and financial stability are paramount.

Corporate Governance

Stakeholder Impact

• Shareholders: The 'going concern' explanatory paragraph and material weaknesses in internal controls raise significant concerns about the company's financial viability and the reliability of its financial reporting, potentially impacting investor confidence and share value.
• Creditors: The 'going concern' issue signals increased risk, which could affect the company's ability to secure future financing or meet existing debt obligations.

Next Steps

• The Company will file an amendment to this Form 8-K within two business days of receiving a letter from Grant Thornton addressed to the Securities and Exchange Commission, stating whether Grant Thornton agrees with the Company's statements in this report.

Key Dates

Recommendation

The filing reveals critical issues that warrant a 'sell' recommendation for a seasoned investor. The explicit mention of 'substantial doubt about the Company's ability to continue as a going concern' by the former auditor is a severe red flag, indicating significant financial distress and potential insolvency. Furthermore, the identified 'material weaknesses in internal control over financial reporting' (general IT controls, insufficient accounting personnel, inadequate segregation of duties) suggest a high risk of financial misstatements, fraud, or operational inefficiencies. These combined factors point to a highly precarious financial position and significant governance deficiencies, making the stock a high-risk investment with substantial downside potential.

Keywords

Glucotrack, GCTK, SEC filing, 8-K, auditor change, independent registered public accounting firm, going concern, material weaknesses, internal controls, financial reporting, corporate governance, CBIZ, Grant Thornton